MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 22nd - 23rd June 2023 at Hilton Boston Logan Airport, Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.
The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.
Associate Director, Bristol-Myers Squibb
Principal Scientist, Novartis
Executive Vice President, Chief Medical Officer, Eikon Therapeutics
Senior Director, Translational Statistics, Teva Pharmaceuticals
Principal Scientist, Translational Science & Diagnostics, Bicycle Therapeutics
Senior Director, Clinical Insights, Danaher Diagnostics
Translational Medicine Scientist, Biomarker & CDx Services, Burning Rock Dx
Program Director, Biorepositories and Biospecimen Research Branch (BBRB), , NIH
CDx Strategy Leader, Regeneron Pharmaceuticals
Founder, Managing Partner, Oncology Ventures
Professor, Innovation Lead Digital Health, Cleveland Clinic
Statistical Biomarker Leader, Sanofi
Senior Vice President, Clinical Development, Foundation Medicine
Associate Director, Biopharma Business Development, Foundation Medicine
Hilton Boston Logan Airport